MoneyWorks4Me

The sales slipped to Rs. 1599.00 millions for the September 2024 quarter as against Rs. 2103.00 millions during the year-ago period.The Company to register a -36.80%  fall in the net profit for the quarter ended September 2024.A decline of 673.00 millions was observed in the OP in the quarter ended September 2024 from 959.00 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202409 202309 % Var
Sales 1599.00 2103.00 -23.97 1599.00 2103.00 -23.97 1599.00 2103.00 -23.97
Other Income 42.00 13.00 223.08 42.00 13.00 223.08 42.00 13.00 223.08
PBIDT 673.00 959.00 -29.82 673.00 959.00 -29.82 673.00 959.00 -29.82
Interest 34.00 0.00 0.00 34.00 0.00 0.00 34.00 0.00 0.00
PBDT 627.00 959.00 -34.62 627.00 959.00 -34.62 627.00 959.00 -34.62
Depreciation 15.00 7.00 114.29 15.00 7.00 114.29 15.00 7.00 114.29
PBT 612.00 952.00 -35.71 612.00 952.00 -35.71 612.00 952.00 -35.71
TAX 162.00 240.00 -32.50 162.00 240.00 -32.50 162.00 240.00 -32.50
Deferred Tax -7.00 -2.00 250.00 -7.00 -2.00 250.00 -7.00 -2.00 250.00
PAT 450.00 712.00 -36.80 450.00 712.00 -36.80 450.00 712.00 -36.80
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 42.09 45.60 -7.70 42.09 45.60 -7.70 42.09 45.60 -7.70
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..